HAMPTON, N.J., Nov. 05, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced data from the Company’s Phase 1b study of barzolvolimab in prurigo nodularis (PN).
Orlando, Florida--(Newsfile Corp. - October 6, 2023) - PN Medical, a cardiopulmonary device manufacturer developing combined respiratory muscle training (cRMT) devices, today announced that it has ...
The government should publish the carrying capacity study on which the decision to create a pre-booking system for Comino was based, the Nationalist Party said on Friday. “The fact that the government ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback